全外显子组测序发现与显性非综合征性胸主动脉瘤相关的新型 EFEMP2 基因变异(c.C247T)

IF 1 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY
Labmedicine Pub Date : 2023-12-19 DOI:10.1093/labmed/lmad109
Parham Sadeghipour, Marzieh Valuian, Serwa Ghasemi, Farnaz Rafiee, Maryam Pourirahim, Mehran Mahmoodian, Majid Maleki, Samira Kalayinia
{"title":"全外显子组测序发现与显性非综合征性胸主动脉瘤相关的新型 EFEMP2 基因变异(c.C247T)","authors":"Parham Sadeghipour, Marzieh Valuian, Serwa Ghasemi, Farnaz Rafiee, Maryam Pourirahim, Mehran Mahmoodian, Majid Maleki, Samira Kalayinia","doi":"10.1093/labmed/lmad109","DOIUrl":null,"url":null,"abstract":"Background Thoracic aortic aneurysm (TAA) is a multifactorial disorder. Familial TAA, which is more clinically aggressive, is associated with a high risk of lethal dissection or rupture. Genetic evaluation can provide TAA patients with personalized treatment and help in predicting risk to family members. Objective The purpose of this investigation was to report a likely pathogenic variant in the EFEMP2 gene that may contribute to TAA in a family with a documented history of the condition. Methods In the index patient, the causative genetic predisposition was identified using whole-exome sequencing. The potential likely pathogenic effect of the candidate variant was further analyzed through bioinformatics analysis, homology modeling, and molecular docking. Results The results revealed a likely pathogenic heterozygous variant, c.247C>T p.Arg83Cys, in exon 4 of the EFEMP2 gene (NM_016938), which was predicted to have disease-causing effects by MutationTaster, PROVEAN, SIFT, and CADD (phred score = 27.6). Conclusion In this study, a likely pathogenic variant in the EFEMP2 gene was identified in an Iranian family with a dominant pattern of autosomal inheritance of TAA. This finding underscores the importance of conducting molecular genetic evaluations in families with nonsyndromic TAA and the significance of early detection of at-risk family members.","PeriodicalId":54328,"journal":{"name":"Labmedicine","volume":"78 1","pages":""},"PeriodicalIF":1.0000,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Whole-exome sequencing uncovers a novel EFEMP2 gene variant (c.C247T) associated with dominant nonsyndromic thoracic aortic aneurysm\",\"authors\":\"Parham Sadeghipour, Marzieh Valuian, Serwa Ghasemi, Farnaz Rafiee, Maryam Pourirahim, Mehran Mahmoodian, Majid Maleki, Samira Kalayinia\",\"doi\":\"10.1093/labmed/lmad109\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background Thoracic aortic aneurysm (TAA) is a multifactorial disorder. Familial TAA, which is more clinically aggressive, is associated with a high risk of lethal dissection or rupture. Genetic evaluation can provide TAA patients with personalized treatment and help in predicting risk to family members. Objective The purpose of this investigation was to report a likely pathogenic variant in the EFEMP2 gene that may contribute to TAA in a family with a documented history of the condition. Methods In the index patient, the causative genetic predisposition was identified using whole-exome sequencing. The potential likely pathogenic effect of the candidate variant was further analyzed through bioinformatics analysis, homology modeling, and molecular docking. Results The results revealed a likely pathogenic heterozygous variant, c.247C>T p.Arg83Cys, in exon 4 of the EFEMP2 gene (NM_016938), which was predicted to have disease-causing effects by MutationTaster, PROVEAN, SIFT, and CADD (phred score = 27.6). Conclusion In this study, a likely pathogenic variant in the EFEMP2 gene was identified in an Iranian family with a dominant pattern of autosomal inheritance of TAA. This finding underscores the importance of conducting molecular genetic evaluations in families with nonsyndromic TAA and the significance of early detection of at-risk family members.\",\"PeriodicalId\":54328,\"journal\":{\"name\":\"Labmedicine\",\"volume\":\"78 1\",\"pages\":\"\"},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2023-12-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Labmedicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/labmed/lmad109\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICAL LABORATORY TECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Labmedicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/labmed/lmad109","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景胸主动脉瘤(TAA)是一种多因素疾病。家族性胸主动脉瘤在临床上更具侵袭性,与致命夹层或破裂的高风险相关。基因评估可为 TAA 患者提供个性化治疗,并有助于预测家庭成员的风险。目的 本研究旨在报告 EFEMP2 基因中一个可能导致 TAA 的致病变异体。方法 通过全外显子组测序确定了患者的致病遗传倾向。通过生物信息学分析、同源建模和分子对接,进一步分析了候选变体的潜在致病效应。结果 结果显示,在 EFEMP2 基因 (NM_016938) 的第 4 外显子中发现了一个可能致病的杂合变异,即 c.247C>T p.Arg83Cys,该变异被 MutationTaster、PROVEAN、SIFT 和 CADD 预测为具有致病效应(phred score = 27.6)。结论 在这项研究中,在一个伊朗家族中发现了 EFEMP2 基因中一个可能的致病变体,该家族具有 TAA 的常染色体显性遗传模式。这一发现强调了对非综合征 TAA 家族进行分子遗传学评估的重要性,以及早期发现高危家族成员的意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Whole-exome sequencing uncovers a novel EFEMP2 gene variant (c.C247T) associated with dominant nonsyndromic thoracic aortic aneurysm
Background Thoracic aortic aneurysm (TAA) is a multifactorial disorder. Familial TAA, which is more clinically aggressive, is associated with a high risk of lethal dissection or rupture. Genetic evaluation can provide TAA patients with personalized treatment and help in predicting risk to family members. Objective The purpose of this investigation was to report a likely pathogenic variant in the EFEMP2 gene that may contribute to TAA in a family with a documented history of the condition. Methods In the index patient, the causative genetic predisposition was identified using whole-exome sequencing. The potential likely pathogenic effect of the candidate variant was further analyzed through bioinformatics analysis, homology modeling, and molecular docking. Results The results revealed a likely pathogenic heterozygous variant, c.247C>T p.Arg83Cys, in exon 4 of the EFEMP2 gene (NM_016938), which was predicted to have disease-causing effects by MutationTaster, PROVEAN, SIFT, and CADD (phred score = 27.6). Conclusion In this study, a likely pathogenic variant in the EFEMP2 gene was identified in an Iranian family with a dominant pattern of autosomal inheritance of TAA. This finding underscores the importance of conducting molecular genetic evaluations in families with nonsyndromic TAA and the significance of early detection of at-risk family members.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Labmedicine
Labmedicine 医学-医学实验技术
CiteScore
2.50
自引率
0.00%
发文量
155
审稿时长
>12 weeks
期刊介绍: Lab Medicine is a peer-reviewed biomedical journal published quarterly by the ASCP and Oxford University Press. The journal invites submission of manuscripts on topics related to clinical chemistry and microbiology, hematology, immunology, transfusion medicine, molecular diagnostics, cytology, histology, and laboratory administration and management. Original research, reviews, and case reports are considered for publication. Lab Medicine is indexed (under the title Laboratory Medicine) by the National Library of Medicine and is included in the PubMed database.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信